Subscribe to RSS
DOI: 10.1055/s-0028-1109131
© Georg Thieme Verlag KG Stuttgart · New York
Akute Polyneuritiden und Polyradikuloneuritiden: Ungewöhnliche Ursachen und deren Pathomechanismen
Acute Polyneuritis and Polyradiculoneuritis: Uncommon Causes and their PathomechanismsPublication History
Publication Date:
03 April 2009 (online)

Zusammenfassung
Akute Polyneuritiden sind insgesamt zwar eine seltene, in entwickelten Ländern jedoch die häufigste Ursache für akut auftretende, generalisierte Lähmungen (> 50 %). Das Guillain-Barré-Syndrom (GBS) ist die häufigste Form dieser Erkrankung. Obwohl sich das klinische und pathologische Spektrum des GBS in den letzten Jahren erheblich erweitert hat, lassen sich etwa 15 % der akuten Polyradikuloneuritiden oder Polyneuritiden trotz erweiterter und revidierter Klassifikationen und Diagnosekriterien keiner der eingeführten GBS-Varianten zuordnen. Die auslösenden Pathomechanismen sind bis heute nicht vollständig geklärt, man vermutet aber, dass sowohl das GBS als auch die „untypischen“ akuten Polyneuritiden Varianten der gleichen, zugrunde liegenden immunologischen Dysregulation sind, jedoch durch pathogenetische Mechanismen unterschiedliche akut-neurologische Bilder hervorrufen. Deshalb sprechen auch akute Polyneuritiden, die sich keiner der eingeführten GBS-Varianten zuordnen lassen, ebenso auf eine immunmodulatorische Therapie (die nicht GBS-spezifisch ist) an, was ihr Erkennen und frühzeitiges Behandeln essenziell macht. Da bei den Immunneuropathien kein valider diagnostischer Marker existiert und das Krankheitsbild sehr variabel bleibt, wird die Diagnose klinisch gestellt und ist nicht selten eine Herausforderung. Den akuten Polyneuritiden, die sich keiner der eingeführten GBS-Varianten zuordnen lassen, scheint gemein, dass sie seltener infektassoziiert auftreten und häufiger mit ungewöhnlichen Ursachen und Auslösern assoziiert sind. In diesem Beitrag schildern wir unsere Erfahrungen mit ungewöhnlichen Varianten und Auslösern akuter Polyneuritiden und Polyradikuloneuritiden, die nicht den internationalen Diagnosekriterien des GBS entsprechen. Wir liefern eine ausführliche Literaturübersicht über die möglichen Pathomechanismen und diskutieren mögliche Dispositionen zur Entwicklung der Erkrankung.
Abstract
Although the total incidence rate of acute inflammatory polyneuropathies is low, it is the most frequent cause of acute progressive, generalized paresis in developed countries (> 50 %). The most common form of the disease is the Guillain-Barré syndrome (GBS). Even though the clinical and pathologic spectrum of GBS has substantially grown over the last decade, about 15 % of cases of acute polyneuritis or polyradiculoneuritis do not fulfil the revised and extended diagnostic criteria and classification for GBS and its variants. The underlying pathogenesis still remains unclear. It is assumed that these “untypical” acute inflammatory polyneuropathies and cases fulfilling the GBS criteria are variants of the same underlying immune disorder, but that pathogenetic mechanisms produce different acute neurological syndromes. Thus, immunotherapy (which is not GBS-specific) is also effective for treating acute inflammatory polyneuropathies that do not fulfil the diagnostic criteria for GBS, and early diagnosis and treatment of these cases is essential. Since no reliable serological and electrodiagnostic markers of autoimmune neuropathies are currently available, the diagnosis is based on its clinical presentation. However, clinical symptoms are variable, and a rational diagnostic decision can be challenging. Thus, it is important to know that acute inflammatory polyneuropathies not fulfilling the diagnostic criteria of GBS are less often preceded by an infective condition but frequently associated with uncommon causes and triggers. This report presents our experiences with uncommon variants of inflammatory polyneuropathies and polyradiculoneuritides that do not fulfil the international diagnostic criteria for GBS. We provide a detailed review of the pertinent literature discussing possible pathomechanisms, its clinical associations and possible dispositions.
Schlüsselwörter
akute Polyneuritiden - Immunneuropathien - Guillan-Barré-Syndrom - klinische Varianten - Autoimmunerkrankungen
Key words
acute polyneuritis - immunomediated neuropathies - Guillain-Barré-Syndrome - clinical variants - autoimmune disease
Literatur
- 1
Gold R, Bayas A, Toyka K V.
Immunneuropathien – Aktuelle Aspekte der Diagnostik und Therapie.
Nervenarzt.
2005;
76
1009-1021
MissingFormLabel
- 2
Asbury A K, Cornblath D R.
Assessment of current diagnostic criteria for Guillain-Barre syndrome.
Ann Neurol.
1990;
27 (Suppl)
S21-S24
MissingFormLabel
- 3
Van der Meche F G, Van Doorn P A, Meulstee J. et al .
Diagnostic and classification criteria for the Guillain-Barre syndrome.
Eur Neurol.
2001;
45
133-139
MissingFormLabel
- 4
Govoni V, Granieri E, Tola M R. et al .
The frequency of clinical variants of Guillain-Barre syndrome in Ferrara, Italy.
J Neurol.
1999;
246
1010-1014
MissingFormLabel
- 5
Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology .
Guillain-Barre syndrome variants in Emilia-Romagna, Italy, 1992 – 3: incidence, clinical
features, and prognosis.
J Neurol Neurosurg Psychiatry.
1998;
65
218-224
MissingFormLabel
- 6
Thomas P K.
The Guillain-Barre syndrome: no longer a simple concept.
J Neurol.
1992;
239
361-362
MissingFormLabel
- 7
Beghi E, Bogliun G.
The Guillain-Barre syndrome (GBS). Implementation of a register of the disease on
a nationwide basis. Italian GBS Study Group.
Ital J Neurol Sci.
1996;
17
355-361
MissingFormLabel
- 8
Hadden R D, Cornblath D R, Hughes R A. et al .
Electrophysiological classification of Guillain-Barre syndrome: clinical associations
and outcome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group.
Ann Neurol.
1998;
44
780-788
MissingFormLabel
- 9
Hughes R A, Hadden R D, Gregson N A. et al .
Pathogenesis of Guillain-Barre syndrome.
J Neuroimmunol.
1999;
100
74-97
MissingFormLabel
- 10
Sladky J T.
Guillain-Barre syndrome: blind men describe an elephant?.
Neurology.
2007;
69
1647-1649
MissingFormLabel
- 11
Rodriguez V, Kuehnle I, Heslop H E. et al .
Guillain-Barre syndrome after allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant.
2002;
29
515-517
MissingFormLabel
- 12
Chan L Y, Tsui M H, Leung T N.
Guillain-Barre syndrome in pregnancy.
Acta Obstet Gynecol Scand.
2004;
83
319-325
MissingFormLabel
- 13 Arnason B GW, Soliven B. Acute inflammatory demyelinating polyradiculoneuropathy. Dyck PJ, Thomas PK, Griffin JW Peripheral neuropathy Philadelphia; Saunders 1993 3. Aufl: 1437-1497
MissingFormLabel
- 14
Flores-Barragan J M, Martinez-Palomeque G, Ibanez R. et al .
Guillain-Barre syndrome as a complication of epidural anaesthesia.
Rev Neurol.
2006;
42
631-632
MissingFormLabel
- 15
De Freitas G R, Freitas M R, Ferreira M C.
Guillain-Barre syndrome and head trauma. Case report.
Arq Neuropsiquiatr.
1997;
55
315-318
MissingFormLabel
- 16
De Freitas M R, Nascimento O J, Harouche M B. et al .
Guillain-Barre syndrome after brachial plexus trauma: case report.
Arq Neuropsiquiatr.
2006;
64
1039-1040
MissingFormLabel
- 17
Ropper A H.
Unusual clinical variants and signs in Guillain-Barre syndrome.
Arch Neurol.
1986;
43
1150-1152
MissingFormLabel
- 18
Hughes R A, Swan A V, Raphael J C. et al .
Immunotherapy for Guillain-Barre syndrome: a systematic review.
Brain.
2007;
130
2245-2257
MissingFormLabel
- 19
Linker R A, Gold de R.
Use of intravenous immunoglobulin and plasma exchange in neurological disease.
Curr Opin Neurol.
2008;
21
358-365
MissingFormLabel
- 20
Lehmann H C, Hartung H P, Meyer Z u HG. et al .
Plasma exchange in immune-mediated neuropathies.
Curr Opin Neurol.
2008;
21
547-554
MissingFormLabel
- 21
Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group .
Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments
in Guillain-Barre syndrome.
Lancet.
1997;
349
225-230
MissingFormLabel
- 22 Bundesärztekammer .Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten
(Hämotherapie). Köln; Deutscher Ärzte-Verlag 2008
MissingFormLabel
- 23
Anthoney D A, Bone I, Evans T R.
Inflammatory demyelinating polyneuropathy: a complication of immunotherapy in malignant
melanoma.
Ann Oncol.
2000;
11
1197-1200
MissingFormLabel
- 24
Adler A J.
Mechanisms of T cell tolerance and suppression in cancer mediated by tumor-associated
antigens and hormones.
Curr Cancer Drug Targets.
2007;
7
3-14
MissingFormLabel
- 25
Vigliani M C, Magistrello M, Polo P. et al .
Risk of cancer in patients with Guillain-Barre syndrome (GBS). A population-based
study.
J Neurol.
2004;
251
321-326
MissingFormLabel
- 26
Smith W R, Wilson A F.
Guillan-Barre syndrome in heroin addiction.
JAMA.
1975;
231
1367-1368
MissingFormLabel
- 27 Weimer L H. Spinal and neuromuscular complications of substance abuse. Miller AE, Marra C, Mancall EL Neurologic complications of substance abuse Philadelphia; 2004 10. Aufl: 115-143
MissingFormLabel
- 28
Kraus J, Baumeier A, Boentert M. et al .
Acute toxic polyradiculopathy after exorbitant intracarotid substance abuse.
J Neurol.
2006;
253
815-816
MissingFormLabel
- 29
Screnci D, McKeage M J.
Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective
approaches.
J Inorg Biochem.
1999;
77
105-110
MissingFormLabel
- 30
Kiefer R, Kieseier B C, Stoll G. et al .
The role of macrophages in immune-mediated damage to the peripheral nervous system.
Prog Neurobiol.
2001;
64
109-127
MissingFormLabel
- 31
Tho L M, O’Leary C P, Horrocks I. et al .
Guillain-Barre syndrome occurring after adjuvant chemo-radiotherapy for endometrial
cancer.
Gynecol Oncol.
2006;
100
615-617
MissingFormLabel
- 32
Cicero G, Fulfaro F, Caraceni A. et al .
A case of guillain-barre syndrome in a patient with non small cell lung cancer treated
with chemotherapy.
J Chemother.
2006;
18
325-327
MissingFormLabel
- 33
Terenghi F, Ardolino G, Nobile-Orazio E.
Guillain-Barre syndrome after combined CHOP and rituximab therapy in non-Hodgkin lymphoma.
J Peripher Nerv Syst.
2007;
12
142-143
MissingFormLabel
- 34
Dabby R, Djaldetti R, Gilad R. et al .
Acute heroin-related neuropathy.
J Peripher Nerv Syst.
2006;
11
304-309
MissingFormLabel
- 35
Bogucki A, Gluszcz-Zielinska A.
Focal conduction block in n-hexane polyneuropathy.
Muscle Nerve.
1999;
22
425-426
MissingFormLabel
- 36
Donofrio P D, Wilbourn A J, Albers J W. et al .
Acute arsenic intoxication presenting as Guillain-Barre-like syndrome.
Muscle Nerve.
1987;
10
114-120
MissingFormLabel
- 37
Kaplan J G, Kessler J, Rosenberg N. et al .
Sensory neuropathy associated with Dursban (chlorpyrifos) exposure.
Neurology.
1993;
43
2193-2196
MissingFormLabel
- 38
Neundorfer B, Reinhardt F.
Polyneuropathien unter Lösungsmitteleinwirkung.
Fortschr Neurol Psychiatr.
1998;
66
539-544
MissingFormLabel
- 39
Teo E, Azwra A, Jones R. et al .
Guillain-Barre syndrome following immune reconstitution after antiretroviral therapy
for primary HIV infection.
J HIV Ther.
2007;
12
62-63
MissingFormLabel
- 40
La Rocca R V, Meer J, Gilliatt R W. et al .
Suramin-induced polyneuropathy.
Neurology.
1990;
40
954-960
MissingFormLabel
- 41
Pellissier J F, Pouget J, Cros D. et al .
Peripheral neuropathy induced by amiodarone chlorhydrate. A clinicopathological study.
J Neurol Sci.
1984;
63
251-266
MissingFormLabel
- 42
Taylor B V, Mastaglia F L, Stell R.
Guillain-Barre syndrome complicating treatment with streptokinase.
Med J Aust.
1995;
162
214-215
MissingFormLabel
- 43
Fung H B, Guo Y.
Enfuvirtide: a fusion inhibitor for the treatment of HIV infection.
Clin Ther.
2004;
26
352-378
MissingFormLabel
- 44
Kraus J, Teismann I, Kellinghaus C. et al .
Temporal coincidence between AMAN type of GBS and myasthenia gravis.
J Neurol.
2007;
254
264-265
MissingFormLabel
- 45
Mochizuki H, Kamakura K, Masaki T. et al .
Motor dominant neuropathy in Sjogren’s syndrome: report of two cases.
Intern Med.
2002;
41
142-146
MissingFormLabel
- 46
Martin S, Rieckmann P, Melchers I. et al .
Circulating forms of ICAM-3 (cICAM-3). Elevated levels in autoimmune diseases and
lack of association with cICAM-1.
J Immunol.
1995;
154
1951-1955
MissingFormLabel
- 47
Creange A, Sharshar T, Planchenault T. et al .
Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barre
syndrome.
Neurology.
1999;
53
1683-1691
MissingFormLabel
- 48
Misasi R, Dionisi S, Farilla L. et al .
Gangliosides and autoimmune diabetes.
Diabetes Metab Rev.
1997;
13
163-179
MissingFormLabel
- 49
Schattner A.
Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune
manifestations after viral vaccines.
Vaccine.
2005;
23
3876-3886
MissingFormLabel
- 50
Bradbury K, Aparicio S R, Sumner D W. et al .
Comparison of in vitro demyelination and cytotoxicity of humoral factors in multiple
sclerosis and other neurological diseases.
J Neurol Sci.
1985;
70
167-181
MissingFormLabel
- 51
Puertas-Munoz I, Miranda-Lloret P, Lagares A. et al .
Guillain-Barre syndrome following resection of glioblastoma multiforme.
Rev Neurol.
2004;
39
1137-1139
MissingFormLabel
- 52
Eimil M, Benito-Leon J.
Guillain-Barre-like syndrome heralding small-cell lung cancer.
Eur J Neurol.
2007;
14
e15-e16
MissingFormLabel
- 53
Nokura K, Nagamatsu M, Inagaki T. et al .
Acute motor and sensory neuronopathy associated with small-cell lung cancer: a clinicopathological
study.
Neuropathology.
2006;
26
329-337
MissingFormLabel
- 54
Christodoulou C, Anastasopoulos D, Visvikis A. et al .
Guillain-Barre syndrome in a patient with metastatic colon cancer receiving oxaliplatin-based
chemotherapy.
Anticancer Drugs.
2004;
15
997-999
MissingFormLabel
- 55
Swan C H, Wharton B A.
Polyneuritis and renal carcinoma.
Lancet.
1963;
2
383-384
MissingFormLabel
- 56
Phan T G, Hersch M, Zagami A S.
Guillain-Barre syndrome and adenocarcinoma of the gall bladder: a paraneoplastic phenomenon?.
Muscle Nerve.
1999;
22
141-142
MissingFormLabel
- 57
Mineo T C, Biancari F, Casciani C U.
Polyradiculoneuritis as an initial manifestation of bronchial carcinoma.
J Thorac Cardiovasc Surg.
1995;
109
1254
MissingFormLabel
- 58
Nakatsuji Y, Sadahiro S, Watanabe S. et al .
Leptomeningeal signet-ring cell carcinomatosis presenting with ophthalmoplegia, areflexia
and ataxia.
Clin Neuropathol.
2001;
20
272-275
MissingFormLabel
- 59
Ben Simon G J, McCann J D, Barth N. et al .
Partial resolution of acute ascending motor polyneuropathy after enucleation of an
eye with metastatic melanoma.
Br J Ophthalmol.
2004;
88
847
MissingFormLabel
- 60
Csepany T, Boczan J, Magyar M T. et al .
Miller Fisher syndrome – manifestation of lung cancer in a previously apparently healthy
individual.
J Neurol.
2004;
251
898-900
MissingFormLabel
- 61
Alimonti A, Di Cosimo S, Di Stani F. et al .
Subacute motor weakness and left renal mass.
Am J Med.
2003;
114
706-708
MissingFormLabel
- 62
Krampfl K, Mohammadi B, Buchwald B. et al .
IgG from patients with Guillain-Barre syndrome interact with nicotinic acetylcholine
receptor channels.
Muscle Nerve.
2003;
27
435-441
MissingFormLabel
- 63
Toshniwal P.
Demyelinating optic neuropathy with Miller-Fisher syndrome. The case for overlap syndromes
with central and peripheral demyelination.
J Neurol.
1987;
234
353-358
MissingFormLabel
- 64
Hawley R J, Madrid R.
Post-infectious central and peripheral nervous system diseases in patient with Devic’s
disease and Guillain-Barre syndrome.
Eur J Neurol.
2003;
10
600
MissingFormLabel
- 65
Hughes R A, Cameron J S, Hall S M. et al .
Multiple mononeuropathy as the initial presentation of systemic lupus erythematosus
– nerve biopsy and response to plasma exchange.
J Neurol.
1982;
228
239-247
MissingFormLabel
- 66
Huynh C, Ho S L, Fong K Y. et al .
Peripheral neuropathy in systemic lupus erythematosus.
J Clin Neurophysiol.
1999;
16
164-168
MissingFormLabel
- 67
Lim A, Lydia A, Rim H. et al .
Focal segmental glomerulosclerosis and Guillain-Barre syndrome associated with Campylobacter
enteritis.
Intern Med J.
2007;
37
724-728
MissingFormLabel
- 68
Heckmann J G, Bohmer K, Druschky A. et al .
Guillain-Barre syndrome in association with focal segmental glomerulosclerosis.
Eur Neurol.
1998;
40
114-115
MissingFormLabel
- 69
Desai S S, Allen E, Deodhar A.
Miller Fisher syndrome in adult onset Still’s disease: case report and review of the
literature of other neurological manifestations.
Rheumatology.
2002;
41
216-222
MissingFormLabel
- 70
Roca B, Ferrer D, Calvo B.
Temporal arteriitis and Guillain-Barre syndrome.
South Med J.
2002;
95
1081-1082
MissingFormLabel
- 71
Polizzi A, Ruggieri M, Vecchio I. et al .
Autoimmune thyroiditis and acquired demyelinating polyradiculoneuropathy.
Clin Neurol Neurosurg.
2001;
103
151-154
MissingFormLabel
- 72
Potz G, Neundorfer B.
Polyradicular neuritis and Hashimoto’s thyreoiditis.
J Neurol.
1975;
210
283-289
MissingFormLabel
- 73
Bosch X, Navarro M, Lopez-Soto A. et al .
Primary polyartheritis nodosa presenting as acute symmetric quadriplegia.
Clin Exp Rheumatol.
1999;
17
232-234
MissingFormLabel
- 74
Goraya J S, Jayashree M, Ghosh D. et al .
Guillain-Barre syndrome in a child with Henoch-Schonlein Purpura.
Scand J Rheumatol.
1998;
27
310-312
MissingFormLabel
- 75
Moormann B, Herath H, Mann O. et al .
Beteiligung des peripheren Nervensystems bei Morbus Crohn.
Nervenarzt.
1999;
70
1107-1111
MissingFormLabel
- 76
Kohli R S, Bleibel W, Bleibel H.
Concurrent immune thrombocytopenic purpura and Guillain-Barre syndrome in a patient
with Hashimoto’s thyreoiditis.
Am J Hematol.
2007;
82
307-308
MissingFormLabel
- 77
Zeidman L A, Fahey C D, Grinblatt D L. et al .
Immunoglobulin for concurrent Guillain-Barre and immune thrombocytopenic purpura.
Pediatr Neurol.
2006;
34
60-62
MissingFormLabel
- 78
Pryszmont M, Sierakowski S, Poplawska T. et al .
Guillain-Barre syndrome in a patient with primary sicca syndrome.
Neurol Neurochir Pol.
2000;
34
1235-1241
MissingFormLabel
- 79
Schulze B K, Klein B, Oelerich M. et al .
Koinzidenz von Guillain-Barré-Syndrom und Myelitis.
Nervenarzt.
2007;
78
445-450
MissingFormLabel
- 80
Rouanet-Larriviere M, Vital C, Arne P. et al .
Guillain-Barre syndrome occurring in two women after ketoacidosic comatose state disclosing
an insulin-dependent diabetes mellitus.
J Peripher Nerv Syst.
2000;
5
27-31
MissingFormLabel
- 81
Kawabata H, Honda M, Kawamura T. et al .
A case of primary sclerosing cholangitis (PSC) complicated with acute inflammatory
demyelinating polyradiculoneuropathy.
Nippon Shokakibyo Gakkai Zasshi.
2002;
99
1503-1507
MissingFormLabel
- 82
Gutzler F, Andrassy K, Kommerell B. et al .
Guillain-Barré-Polyneuropathie bei Wegenerscher Granulomatose mit pulmorenalem Syndrom.
Dtsch Med Wochenschr.
1990;
115
372-377
MissingFormLabel
Dr. med. Thomas Duning
Klinik und Poliklinik für Neurologie Universitätsklinikum Münster
Albert-Schweitzer-Str. 33
48151 Münster
Email: duningt@uni-muenster.de